How an Implanted Sensor Checks Its Own Accuracy Over Time
This patent describes a method for an electronic device to continuously monitor and evaluate how well an implanted medical sensor, like a glucose sensor, is working by tracking changes in its accuracy over time.
Original patent title: “Analyte sensor”
This patent describes a method for an electronic device to continuously monitor and evaluate how well an implanted medical sensor, like a glucose sensor, is working by tracking changes in its accuracy over time. Granted to Dexcom in 2018 with 15 claims and 15 forward citations, and it is expected to expire in 2033.
Coverage
What does this patent actually cover?
The patent describes a method for an electronic device to check if an implanted sensor, such as one measuring glucose, is still accurate. It works by first "receiving sensor data from an analyte sensor implanted in a host" (ClaimclaimA numbered sentence at the end of a patent that legally defines what the inventor owns. The most important section.Read more → 1). Next, the device "intermittently calculat[es] a sensitivity of the analyte sensor" (Claim 1). Sensitivity here refers to how effectively the sensor converts the measured substance into a signal. Finally, the device "evaluat[es], using an electronic device, a change in sensitivity by evaluating a plurality of time-spaced sensitivity calculations over a predetermined time period" (Claim 1). This evaluation uses "a priori sensitivity information" to create an "expected sensitivity profile that is a function of time" (Claim 1). For example, if a glucose sensor's accuracy typically drops after 5 days, the system uses this known pattern to better interpret current sensitivity changes.
The gap
What does this patent NOT cover?
- Does not cover systems that only measure analyte values without also evaluating changes in the sensor's sensitivity.
- Does not cover sensors that are not implanted in a host's body.
- Does not cover methods that do not use "a priori sensitivity information" to generate an "expected sensitivity profile."
- Does not cover systems that only calculate sensitivity once, rather than "intermittently" and evaluating "a plurality of time-spaced sensitivity calculations."
- Does not cover systems that do not use an electronic device to perform the sensitivity evaluation.
These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.
Key facts
What made this novel
The clever part is using "a priori sensitivity information" – basically, knowing how a sensor's accuracy typically changes over its lifespan – to create an "expected sensitivity profile." This allows the system to not just detect a change in sensitivity, but to evaluate it against a known pattern, making the accuracy assessment more intelligent and predictive.
The Patent Drawing

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.
Where you've seen this
Real-world examples
Dexcom G6 Continuous Glucose Monitoring System
Dexcom G7 Continuous Glucose Monitoring System
Other continuous glucose monitoring (CGM) devices that adjust for sensor drift
Why it matters
The bigger picture
For people managing conditions like diabetes, the accuracy of continuous glucose monitors (CGMs) is crucial. This patent addresses a key challenge: how sensor accuracy can change over time once implanted. By continuously evaluating and potentially correcting for these changes, it helps ensure that patients and their doctors receive reliable data, leading to better health decisions and improved safety.
Filed
November 5, 2013
Granted
August 21, 2018
Market context
Who's building on this
Companies in this space
Dexcom, the original assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →, continues to be a leader in continuous glucose monitoring (CGM) technology, constantly improving sensor accuracy and longevity. Other major players like Abbott (with its FreeStyle Libre systems) and Medtronic also develop and refine similar technologies to ensure the reliability of their implanted sensors for diabetes management.
Market impact
This patent contributed to the ongoing improvement of continuous glucose monitoring (CGM) device reliability and accuracy. By providing a method to account for sensor drift, it helped build user trust and enabled CGMs to become a more widely adopted tool for diabetes management. This increased reliability helped expand the market for long-term implanted sensors.
Claim 1 — Plain English
What this patent covers
The patent describes a method for an electronic device to check if an implanted sensor, such as one measuring glucose, is still accurate. It works by first "receiving sensor data from an analyte sensor implanted in a host" (Claim 1). Next, the device "intermittently calculat[es] a sensitivity of the analyte sensor" (Claim 1). Sensitivity here refers to how effectively the sensor converts the measured substance into a signal. Finally, the device "evaluat[es], using an electronic device, a change in sensitivity by evaluating a plurality of time-spaced sensitivity calculations over a predetermined time period" (Claim 1). This evaluation uses "a priori sensitivity information" to create an "expected sensitivity profile that is a function of time" (Claim 1). For example, if a glucose sensor's accuracy typically drops after 5 days, the system uses this known pattern to better interpret current sensitivity changes.
The clever bit
The clever part is using "a priori sensitivity information" – basically, knowing how a sensor's accuracy typically changes over its lifespan – to create an "expected sensitivity profile." This allows the system to not just detect a change in sensitivity, but to evaluate it against a known pattern, making the accuracy assessment more intelligent and predictive.
What it does not cover
- Does not cover systems that only measure analyte values without also evaluating changes in the sensor's sensitivity.
- Does not cover sensors that are not implanted in a host's body.
- Does not cover methods that do not use "a priori sensitivity information" to generate an "expected sensitivity profile."
- Does not cover systems that only calculate sensitivity once, rather than "intermittently" and evaluating "a plurality of time-spaced sensitivity calculations."
- Does not cover systems that do not use an electronic device to perform the sensitivity evaluation.
Patent timeline
Application submitted to the patent office
Application published, typically 18 months after filing
Patent officially issued
Patent enters public domain
PatentBrief Score
Impact Score
Moderate
Citation count
24/40
Moderately cited
Claim breadth
10/20
Broad claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →
Recency
10/20
Granted 5–10 years ago
Assignee scale
0/20
Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →
PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.
Heuristic Value Estimate
What this patent might be worth
$92K – $296K
Midpoint $185K · 7.0 yr remaining · industry ×2.2
Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.
Claim text not yet imported for this patent
The original legal language
Original claims
15 claims as filed with the patent office.
Concepts involved
Citations
Patent lineage
Cite this patent
Li, Y., Brister, M. C., Kamath, A. U., & Yang, R. C. (2018). How an Implanted Sensor Checks Its Own Accuracy Over Time (U.S. Patent No. 10,052,055). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/10052055/analyte-sensor-10052055
Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.
Embed
Add this patent to your site
Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.
<div data-patentlens-widget data-patent-number="US10052055"></div> <script src="https://patentbrief.org/embed.js" async></script>
Stay in the loop
Get a weekly digest of new patents.
One email per week. No spam. Unsubscribe anytime.
Keep exploring
Related patents you should know
US 4683195 · 1987
How to Make Billions of Copies of a DNA Segment
This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.
Cetus Corp
US 8697359 · 2014
How to Edit Genes in Human Cells Using an Engineered CRISPR System
This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.
Massachusetts Institute of Technology
US 7657849 · 2010
How the iPhone's Slide-to-Unlock Gesture Works
Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.
Apple Inc
US 4733665 · 1988
How Doctors Implant a Permanent Stent Using a Balloon
This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.
Expandable Grafts Partnership
US 4965188 · 1990
How to Make Many Copies of a DNA Piece with Heat
This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.
Cetus Corp
US 4235871 · 1980
How to Encapsulate Active Materials in Lipid Bubbles Efficiently
This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.
Individual
Semantically similar
You might also find these interesting
US 20230293056 · Dexcom
How Continuous Glucose Monitors Get Accurate Readings
US 11382539 · 2022 · Dexcom
A Catheter That Measures Glucose While Delivering Medication
US 20230263439 · Dexcom
How a Sensor Checks Itself for Accuracy Using Other Body Data
US 9282925 · 2016 · Dexcom
How Glucose Sensors Check Their Own Reliability for Insulin Pumps
More to explore
More in Biotech & Medicine
US 4683195 · 1987 · Cetus Corp
How to Make Billions of Copies of a DNA Segment
US 8697359 · 2014 · Massachusetts Institute of Technology
How to Edit Genes in Human Cells Using an Engineered CRISPR System
US 4733665 · 1988 · Expandable Grafts Partnership
How Doctors Implant a Permanent Stent Using a Balloon
US 4965188 · 1990 · Cetus Corp
How to Make Many Copies of a DNA Piece with Heat
New to patents?
Common Questions
Frequently Asked Questions
What does How an Implanted Sensor Checks Its Own Accuracy Over Time cover?
This patent describes a method for an electronic device to continuously monitor and evaluate how well an implanted medical sensor, like a glucose sensor, is working by tracking changes in its accuracy over time.
Who owns patent US 10052055?
Dexcom owns this patent, granted in 2018.
When does this patent expire?
This patent is expected to expire on November 5, 2033, when the invention enters the public domain.
What is patent US 10052055 cited by?
This patent has been cited by 15 later patents that build on its ideas.
What problem does this patent solve?
For people managing conditions like diabetes, the accuracy of continuous glucose monitors (CGMs) is crucial. This patent addresses a key challenge: how sensor accuracy can change over time once implanted. By continuously evaluating and potentially correcting for these changes, it helps ensure that patients and their doctors receive reliable data, leading to better health decisions and improved safety.
What does this patent NOT cover?
Does not cover systems that only measure analyte values without also evaluating changes in the sensor's sensitivity.
Same assignee
More from Dexcom
Patent monitoring






